Queensland, Other –News Direct– Graphene Manufacturing Group Ltd.
BRISBANE, QUEENSLAND, AUSTRALIA – TheNewswire – September 13, 2021 – Graphene Manufacturing Group Ltd. (TSXV: GMG) (“GMG” or the “Company”) is pleased to formalize its support to the Queensland University of Technology – Center for Biomedical Technologies (“CBT”) for the development of piezo-supercapacitors for self-powered medical implants by a pilot project agreement (the “Agreement”). The agreement details GMG’s contribution in terms of expertise and graphene for the project.
Click on the image to view it in full size
Figure 1: Requirements of human peizoelectric supercapacitors
The initial Industry Engagement Grant titled “Piezoelectric Supercapacitors for Self-Powered Medical Implants” was awarded to Professor Cameron Brown, Associate Professor Deepak Dubal, Dr Hong Duc Pham and GMG Scientific Director Dr Ashok Kumar Nanjundan.
Most modern electric medical implants (such as pacemakers, insulin pumps and as shown in Figure 1) actively regulate or replace bodily functions, and therefore require batteries that can operate reliably for many years without failure. Implanted batteries typically require secondary surgeries for replacement, causing significant inconvenience to patients in the form of high costs, discomfort, and the risk of infection.
This project aims to develop the capacity of self-charging medical implants by designing a new power unit called “Piezo-Supercapacitor”, which can capture the movements of the human body, convert this energy into electricity and store it, in a single unit. The concept is based on a mechanism that hybridizes the two processes into one, where mechanical energy is directly converted and stored simultaneously as electrochemical energy without going through the intermediate step of converting into electricity.
GMG is an Australian clean and disruptive technology company listed on the Canadian Venture Exchange (TSXV: GMG) that produces graphene and hydrogen by cracking methane (natural gas) instead of mining graphite. Using the company’s proprietary process, GMG can produce high quality, low cost, scalable, “tunable” and free / low contaminant graphene, resulting in demonstrated cost and environmental improvements. in a number of ecological / technological applications globally. Using this low entry cost source of graphene, the Company is developing value-added products that target the massive energy efficiency and energy storage markets.
The company is also pursuing additional opportunities for GMG Graphene, including the development of next generation batteries, the collaboration with world-renowned universities in Australia and the search for opportunities to improve the performance of lube oil, biodiesel. and diesel fuels.
For more information, please contact:
– Craig Nicol, CEO and Managing Director of the company at [email protected], +61 415 445 223
– Leo Karabelas at Focus Communications, [email protected], +1 647 689 6041
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Caution regarding forward-looking statements
This press release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities laws. The forward-looking statements contained herein are made as of the date of this press release only, and the Company assumes no obligation to update or revise them to reflect new information, estimates or opinions, future events or results. or otherwise, unless required by applicable law. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is planned”, “budgets”, “planned”, “estimates”, “forecasts”, ” predicts “,” plans “,” intends “,” aims “,” aims “,” anticipates “or” believes “or variations (including negative variations) of these words and phrases or may be identified by statements that certain actions “may”, “could”, “should”, “would”, “could” or “will” be taken, occur or be achieved. Forward-looking information contained in this press release includes, without limited thereto, statements relating to the development of the piezo-supercapacitor by GMG contemplated by the agreement and its viability and effectiveness, as well as the advantages of the piezo-supercapacitor over implanted batteries. Forward-looking statements and information are subject to various known risks and uncertainties and unknown, including, but not limited to, the risk factors set forth under the heading “Risk Factors” in the Company’s final detailed prospectus dated March 31. 2021 available for review on Company Profile at www.sedar.com, many of which are beyond the Company’s ability to control or predict. These risk factors may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied therein, and are developed on the basis of assumptions regarding these risks, uncertainties and other factors set forth herein. , including the assumptions that the development and efficiency of the piezo-supercapacitor will be in line with expected results. This forward-looking information represents management’s best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary significantly. Therefore, readers are advised not to place undue reliance on forward-looking statements or information.
See the source version on newsdirect.com: https://newsdirect.com/news/gmg-supports-queensland-university-of-technology-development-of-piezo-supercapacitors-for-self-powered-medical-implants-371222338